16p11.2 duplication

What it is, symptoms and effects

From: MedlinePlus Genetics, National Library of Medicine

16p11.2 duplication is a chromosomal change in which a small amount of genetic material within chromosome 16 is abnormally copied (duplicated). The duplication occurs near the middle of the chromosome at a location designated p11.2. This duplication can have a variety of effects. Common characteristics that occur in people with a 16p11.2 duplication include a low weight; a small head size (microcephaly); and developmental delay, especially in speech and language. Affected individuals also have an increased risk of behavioral problems. However, some people with the duplication have no identified physical or behavioral abnormalities.

Developmental delay and intellectual disability can occur in people with a 16p11.2 duplication. Approximately one-third of children with this condition have delays in developing physical skills such as sitting, crawling, or walking. The average IQ of affected individuals is about 26 points lower than that of their parents without the duplication. About 80 percent of people with a 16p11.2 duplication have problems related to speech or language. Both expressive language skills (vocabulary and the production of speech) and receptive language skills (the ability to understand speech) can be affected.

One of the most common behavioral problems associated with this chromosomal change is attention-deficit/hyperactivity disorder (ADHD). Autism spectrum disorder, which affects communication and social skills, is diagnosed in about one in five people with a 16p11.2 duplication. Affected individuals also have an increased risk of mental health problems, including schizophrenia, anxiety, and depression. Recurrent seizures are possible in this condition, although they do not occur in most affected individuals.

Other abnormalities that can occur with a 16p11.2 duplication include malformations of the kidneys and urinary tract. However, there is no particular pattern of physical abnormalities that characterizes 16p11.2 duplications; signs and symptoms related to the chromosomal change vary even among affected members of the same family.

Causes and biological mechanisms

From: MedlinePlus Genetics, National Library of Medicine

People with a 16p11.2 duplication have an extra copy of a segment of genetic material on the short (p) arm of chromosome 16 at a position known as p11.2. This duplication affects one of the two copies of chromosome 16 in each cell. The length of the duplicated segment is most often about 600,000 DNA building blocks (base pairs), also written as 600 kilobases (kb). The 600 kb region contains more than 25 genes, and little is known about the function of most of these genes. Researchers are working to determine how the extra genetic material contributes to the features of 16p11.2 duplication.

Inheritance and family implications

From: MedlinePlus Genetics, National Library of Medicine

16p11.2 duplications have an autosomal dominant inheritance pattern, which means that a duplication in one copy of chromosome 16 in each cell is sufficient to cause the condition. Most affected individuals inherit the duplication from one affected parent; they may have similar characteristics of the condition as the parent, or they may be either more or less severely affected. However, in some cases 16p11.2 duplications are not inherited. Instead, they occur as random events during the formation of reproductive cells (eggs and sperm) or in early fetal development. People with a new duplication typically have no history of related signs or symptoms in their family, although their children can inherit the chromosomal change.

How common is it?

From: MedlinePlus Genetics, National Library of Medicine

16p11.2 duplications have been estimated to occur in about 3 in 10,000 people. These changes are present in about 4 in 10,000 people who have mental health problems or difficulties with speech and language. Many people with the duplication are likely never diagnosed because there are many causes of these problems, and some people with the duplication have no related health or developmental problems.

Which doctor should you see?

The suggested department for discussing 16p11.2 duplication is Clinical Genetics, with a clinical geneticist as the relevant type of clinician. Paediatrician (children) or physician (adults), with clinical geneticist referral.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

• Does the exact genetic or chromosome finding explain the observed features?
• Would a genetic counsellor help the family understand the result?
• Which organ-specific assessments are appropriate for this particular diagnosis?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for 16p11.2 duplication. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.